Valeant Pharmaceuticals to Acquire U.S. and Canadian Rights to Zovirax - Drugs.com MedNews
Links shared publicly online about this topic.
- 533total visits
Valeant Pharmaceuticals to Acquire U.S. and Canadian Rights to Zovirax - Drugs.com MedNews
Valeant Pharmaceuticals International, Inc. (NYSE VRX) (TSX VRX) today announced that its subsidiary, Biovail Laboratories International SRL ( BLS ), has signed
View full resource at drugs.com
Tags: Herpes Medication, Drug, Pharma, Zovirax
Most Recently Shared on February 3, 2011 at 6:06 pm By:
Valeant Pharmaceuticals to Acquire U.S. and Canadian Rights to Zovirax: MISSISSAUGA, Ontario, Feb. 3, 2011... http://bit.ly/g3MNfY #drug
PharmaLive: Valeant Pharmaceuticals to Acquire U.S. and Canadian Rights to Zovirax
pharmalive.com — “PharmaLive: Valeant Pharmaceuticals to Acquire U.S. and Canadian Rights to Zovirax” View full resource at pharmalive.com
Most Recently Shared on February 3, 2011 at 9:09 pm By:
PharmaLive Pharma and Health News
Daily Advantage - Valeant Buys Zovirax From Glaxo for $300 Million - http://tinyurl.com/4qbdoag
Advertisement
